Watanabe Megumi, Tsugeno Yuri, Sato Tatsuya, Higashide Megumi, Umetsu Araya, Furuhashi Masato, Ohguro Hiroshi
Department of Ophthalmology, Sapporo Medical University School of Medicine, Sapporo Ika Daigaku, Hirosaki, Japan.
Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine, Sapporo Ika Daigaku, Hirosaki, Japan.
Graefes Arch Clin Exp Ophthalmol. 2025 Jan;263(1):33-46. doi: 10.1007/s00417-024-06481-2. Epub 2024 Jul 23.
In the current investigation, the effects of the mTOR inhibitors, Rapa and Torin1 on the TGF-β2-induced conjunctival fibrogenesis were studied.
Experimental research.
2D and 3D cultures of HconF were subjected to the following analyses; (1) planar proliferation evaluated by TEER (2D), (2) Seahorse metabolic analyses (2D), (3) subepithelial proliferation evaluated by the 3D spheroids' size and hardness, and (4) the mRNA expression of ECM proteins and their regulators (2D and 3D).
Rapa or Torin1 both significantly increased planar proliferation in the non-TGF-β2-treated 2D HconF cells, but in the TGF-β2-treated cells, this proliferation was inhibited by Rapa and enhanced by Torin1. Although Rapa or Torin1 did not affect cellular metabolism in the non-TGF-β2-treated HconF cells, mTOR inhibitors significantly decreased and increased the mitochondrial respiration and the glycolytic capacity, respectively, under conditions of TGF-β2-induced fibrogenesis. Subepithelial proliferation, as evidenced by the hardness of the 3D spheroids, was markedly down-regulated by both Rapa and Torin1 independent of TGF-β2. The mRNA expressions of several ECM molecules and their regulators fluctuated in the cases of 2D vs 3D and TGF-β2 untreated vs treated cultures.
The present findings indicate that mTOR inhibitors have the ability to increase and to reduce planar and subepithelial proliferation in HconF cells, depending on the inhibitor being used.
在当前研究中,研究了mTOR抑制剂雷帕霉素(Rapa)和托瑞司他(Torin1)对转化生长因子-β2(TGF-β2)诱导的结膜纤维化的影响。
实验研究。
对人结膜成纤维细胞(HconF)进行二维和三维培养,并进行以下分析:(1)通过跨上皮电阻(TEER)评估平面增殖(二维);(2)海马代谢分析(二维);(3)通过三维球体的大小和硬度评估上皮下增殖;(4)细胞外基质(ECM)蛋白及其调节剂的mRNA表达(二维和三维)。
Rapa或Torin1均显著增加未用TGF-β2处理的二维HconF细胞的平面增殖,但在TGF-β2处理的细胞中,Rapa抑制这种增殖,而Torin1增强这种增殖。尽管Rapa或Torin1在未用TGF-β2处理的HconF细胞中不影响细胞代谢,但在TGF-β2诱导纤维化的条件下,mTOR抑制剂分别显著降低和增加线粒体呼吸和糖酵解能力。Rapa和Torin1均显著下调三维球体硬度所证明的上皮下增殖,且与TGF-β2无关。在二维与三维以及未处理与TGF-β2处理的培养物中,几种ECM分子及其调节剂的mRNA表达有所波动。
目前的研究结果表明,mTOR抑制剂有能力增加和减少HconF细胞中的平面和上皮下增殖,这取决于所使用的抑制剂。